Cg Oncology Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 6.54 M | $271.52 M | -0.57% | 8.52% |
| DECHENG CAPITAL LLC | 02/12/2026 | 6.37 M | $264.55 M | 0.00% | 8.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 6.00 M | $249.11 M | 8.83% | 7.82% |
| BLACKROCK, INC. | 02/12/2026 | 4.84 M | $201.09 M | 5.60% | 6.31% |
| FMR LLC | 02/17/2026 | 4.30 M | $178.46 M | 11.18% | 5.60% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 3.67 M | $152.39 M | 0.00% | 4.78% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.44 M | $142.96 M | 116.72% | 4.49% |
| STATE STREET CORP | 02/13/2026 | 3.00 M | $124.42 M | 46.42% | 3.91% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/17/2026 | 2.22 M | $92.24 M | 0.00% | 2.90% |
| RTW INVESTMENTS, LP | 02/17/2026 | 2.01 M | $83.54 M | 18.28% | 2.62% |
| UBS GROUP AG | 01/29/2026 | 1.92 M | $79.87 M | -9.52% | 2.51% |
| BRAIDWELL LP | 02/17/2026 | 1.87 M | $77.67 M | -43.03% | 2.44% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.61 M | $66.99 M | -24.54% | 2.10% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.56 M | $64.84 M | 6.28% | 2.04% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 1.52 M | $62.97 M | -12.18% | 1.98% |
| 04/02/2026 | 1.52 M | $62.91 M | 100.00% | 1.97% | |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.51 M | $62.77 M | 2.60% | 1.97% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 1.47 M | $61.15 M | -8.01% | 1.92% |
| DV TRADING LLC | 02/17/2026 | 1.44 M | $59.76 M | 100.00% | 1.88% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.35 M | $56.03 M | 2.35% | 1.76% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.32 M | $55.00 M | -3.09% | 1.73% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.19 M | $49.41 M | 59.02% | 1.55% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 1.13 M | $46.98 M | 0.00% | 1.47% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.10 M | $45.62 M | 0.00% | 1.43% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 1.09 M | $45.29 M | 39.80% | 1.42% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 02/17/2026 | 1.00 M | $41.69 M | 0.00% | 1.31% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 945.83 K | $39.27 M | -52.83% | 1.23% |
| CANDRIAM S.C.A. | 04/30/2026 | 797.62 K | $33.12 M | -23.15% | 1.04% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 772.00 K | $32.05 M | 100.00% | 1.01% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 705.01 K | $29.27 M | 14.85% | 0.92% |
| CITADEL ADVISORS LLC | 02/17/2026 | 681.19 K | $28.28 M | 185.29% | 0.89% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 602.40 K | $25.01 M | 100.00% | 0.79% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 600.00 K | $24.91 M | 100.00% | 0.78% |
| JPMORGAN CHASE & CO | 02/11/2026 | 586.83 K | $24.37 M | 157.52% | 0.76% |
| MORGAN STANLEY | 02/13/2026 | 545.02 K | $22.63 M | -15.16% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 542.70 K | $22.53 M | 3.27% | 0.71% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 530.76 K | $22.04 M | 33.87% | 0.69% |
| WOODLINE PARTNERS LP | 02/17/2026 | 492.50 K | $20.45 M | -13.82% | 0.64% |
| 02/17/2026 | 492.50 K | $20.45 M | 100.00% | 0.64% | |
| NORTHERN TRUST CORP | 02/17/2026 | 481.94 K | $20.01 M | -1.91% | 0.63% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 461.13 K | $19.15 M | 1.94% | 0.60% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/06/2026 | 426.02 K | $17.69 M | -15.39% | 0.56% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 422.59 K | $17.55 M | 100.00% | 0.55% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 410.00 K | $17.02 M | 0.00% | 0.53% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 400.00 K | $16.61 M | 422.88% | 0.52% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 361.16 K | $15.00 M | -43.42% | 0.47% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 312.45 K | $12.97 M | 100.00% | 0.41% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 308.47 K | $12.81 M | 100.00% | 0.40% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 306.85 K | $12.74 M | 100.00% | 0.40% |
| ROSALIND ADVISORS, INC. | 02/12/2026 | 300.00 K | $12.46 M | 0.00% | 0.39% |
Cg Oncology Inc. institutional Ownership - FAQ's
During the previous two years, 252 institutional investors and hedge funds held shares of Cg Oncology Inc.. The most heavily invested institutionals were:
UBS Group AG: 1.31 M
Candriam S.C.A.: 542,036
JENNISON ASSOCIATES LLC: 476,136
VANGUARD FIDUCIARY TRUST CO: 470,257
Fisher Asset Management, LLC: 465,033
DIMENSIONAL FUND ADVISORS LP: 438,673
107.70% of Cg Oncology Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 83.02 M shares in the last 24 months. This purchase volume represents approximately $5.09 B in transactions.